Answers are grounded in this paper and cite their sources.
Tumor-derived small extracellular vesicles (sEVs), including exosomes, affect immune cell function and contribute to the establishment of an immunosuppressive tumor microenvironment. Most studies on tumor-derived sEVs focus on vesicles isolated from cancer cell-conditioned media, but these may differ substantially from those present in the native tumor microenvironment. Direct isolation of sEVs from tumor tissue offers a more biologically relevant approach, but isolated material is often contaminated with intracellular material, protein aggregates, and blood-derived components, making the choice of isolation method critical for reliable downstream analyses. In this study, we compared six EV isolation methods for non-small cell lung cancer tissue: ultracentrifugation, iodixanol-cushioned ultracentrifugation, and four commercial kits based on vesicle precipitation, membrane affinity, immunoaffinity, and phosphatidylserine binding. Using transmission electron microscopy, CD9-targeted fluorescence nanoparticle tracking analysis, and quantitative LC-MS/MS proteomics, we assessed the isolated preparations based on characteristics relevant to sEV characterization, including particle size, vesicle morphology, CD9⁺ particle abundance, and EV-associated protein enrichment. Ultracentrifugation and iodixanol-cushioned ultracentrifugation yielded samples showing the strongest evidence of sEV enrichment, as indicated by vesicle morphology, abundance of CD9⁺ particles, and enrichment of EV-associated proteins. The phosphatidylserine-binding approach resulted in moderate sEV enrichment, whereas the other tested approaches predominantly isolated non-vesicular contaminants. While iodixanol-cushioned ultracentrifugation achieved the highest purity, ultracentrifugation provided comparable purity with considerably higher yield of CD9⁺ particles, used here as a proxy for sEV recovery. Overall, ultracentrifugation offers the best balance between purity and isolation efficiency, making it a practical choice for tissue-derived EV studies and downstream molecular analyses in solid tumors.
No takes yet. Share an insight, caveat, or question.
Biernacka et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: